ADMA BIOLOGICS, INC. Investment Income, Interest
ADMA BIOLOGICS, INC. (ADMA) reported Investment Income, Interest of $1.87 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-02-25
- ADMA BIOLOGICS, INC. investment income, interest for the quarter ending 2025-12-31 was $487.00K, a 18.56% decline year-over-year.
- ADMA BIOLOGICS, INC. investment income, interest for the quarter ending 2025-09-30 was $376.00K, a 43.54% decline year-over-year.
- ADMA BIOLOGICS, INC. investment income, interest for the quarter ending 2025-06-30 was $400.00K, a 10.91% decline year-over-year.
- ADMA BIOLOGICS, INC. investment income, interest for the quarter ending 2025-03-31 was $608.00K, a 58.33% increase year-over-year.
- ADMA BIOLOGICS, INC. investment income, interest for fiscal 2025 was $1.87M, a 10.78% decline from fiscal 2024.
- ADMA BIOLOGICS, INC. investment income, interest for fiscal 2024 was $2.10M, a 29.68% increase from fiscal 2023.
- ADMA BIOLOGICS, INC. investment income, interest for fiscal 2023 was $1.62M, a 3493.33% increase from fiscal 2022.
- ADMA BIOLOGICS, INC. investment income, interest for fiscal 2022 was $45.00K, a 28.57% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed | Investment Income, Interest 64 month | Investment Income, Interest 67 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $487.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $863.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.26M derived: sum of 3 quarters · filed 2026-02-25 | $1.87M 10-K · filed 2026-02-25 | ||||||
| 2025-09-30 | $376.00K 10-Q · filed 2025-11-05 | $776.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.38M 10-Q · filed 2025-11-05 | $1.98M derived: sum of 4 quarters · filed 2026-02-25 | ||||||
| 2025-06-30 | $400.00K 10-Q · filed 2025-08-06 | $1.01M 10-Q · filed 2025-08-06 | $1.61M derived: sum of 3 quarters · filed 2026-02-25 | $2.27M derived: sum of 4 quarters · filed 2026-02-25 | ||||||
| 2025-03-31 | $608.00K 10-Q · filed 2025-05-07 | $1.21M derived: sum of 2 quarters · filed 2026-02-25 | $1.87M derived: sum of 3 quarters · filed 2026-02-25 | $2.32M derived: sum of 4 quarters · filed 2026-02-25 | ||||||
| 2024-12-31 | $598.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.26M derived: sum of 2 quarters · filed 2026-02-25 | $1.71M derived: sum of 3 quarters · filed 2026-02-25 | $2.10M 10-K · filed 2026-02-25 | ||||||
| 2024-09-30 | $666.00K 10-Q · filed 2025-11-05 | $1.11M derived: sum of 2 quarters · filed 2025-11-05 | $1.50M 10-Q · filed 2025-11-05 | $2.11M derived: sum of 4 quarters · filed 2026-02-25 | ||||||
| 2024-06-30 | $449.00K 10-Q · filed 2025-08-06 | $833.00K 10-Q · filed 2025-08-06 | $1.45M derived: sum of 3 quarters · filed 2026-02-25 | $1.87M derived: sum of 4 quarters · filed 2026-02-25 | ||||||
| 2024-03-31 | $384.00K 10-Q · filed 2025-05-07 | $996.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.42M derived: sum of 3 quarters · filed 2026-02-25 | $1.83M derived: sum of 4 quarters · filed 2026-02-25 | ||||||
| 2023-12-31 | $612.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.03M derived: sum of 2 quarters · filed 2026-02-25 | $1.45M derived: sum of 3 quarters · filed 2026-02-25 | $1.62M 10-K · filed 2026-02-25 | ||||||
| 2023-09-30 | $423.00K 10-Q · filed 2024-11-07 | $423.28K 10-Q · filed 2023-11-08 | $837.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.00M 10-Q · filed 2024-11-07 | $1.00M 10-Q · filed 2023-11-08 | $1.01M derived: sum of 4 quarters · filed 2025-03-18 | ||||
| 2023-06-30 | $414.00K 10-Q · filed 2024-08-08 | $414.30K 10-Q · filed 2023-08-09 | $581.00K 10-Q · filed 2024-08-08 | $581.27K 10-Q · filed 2023-08-09 | $582.43K derived: sum of 3 quarters · filed 2025-03-18 | $589.66K derived: sum of 4 quarters · filed 2025-03-18 | ||||
| 2023-03-31 | $166.00K 10-Q · filed 2024-05-09 | $166.97K 10-Q · filed 2023-05-10 | $168.43K derived: sum of 2 quarters · filed 2025-03-18 | $175.66K derived: sum of 3 quarters · filed 2025-03-18 | $177.93K derived: sum of 4 quarters · filed 2025-03-18 | |||||
| 2022-12-31 | $2.43K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $9.66K derived: sum of 2 quarters · filed 2025-03-18 | $11.93K derived: sum of 3 quarters · filed 2025-03-18 | $45.00K 10-K · filed 2025-03-18 | $44.83K 10-K · filed 2023-03-23 | |||||
| 2022-09-30 | $7.24K 10-Q · filed 2023-11-08 | $9.51K derived: sum of 2 quarters · filed 2023-11-08 | $42.57K 10-Q · filed 2023-11-08 | $45.33K derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2022-06-30 | $2.27K 10-Q · filed 2023-08-09 | $35.34K 10-Q · filed 2023-08-09 | $38.10K derived: sum of 3 quarters · filed 2024-02-28 | $42.35K derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2022-03-31 | $33.07K 10-Q · filed 2023-05-10 | $35.83K derived: sum of 2 quarters · filed 2024-02-28 | $40.08K derived: sum of 3 quarters · filed 2024-02-28 | $46.01K derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2021-12-31 | $2.76K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $7.01K derived: sum of 2 quarters · filed 2024-02-28 | $12.94K derived: sum of 3 quarters · filed 2024-02-28 | $35.00K 10-K · filed 2024-02-28 | $34.53K 10-K · filed 2022-03-24 | |||||
| 2021-09-30 | $4.26K 10-Q · filed 2022-11-09 | $10.18K derived: sum of 2 quarters · filed 2022-11-09 | $32.24K 10-Q · filed 2022-11-09 | $51.72K derived: sum of 4 quarters · filed 2022-11-09 | ||||||
| 2021-06-30 | $5.93K 10-Q · filed 2022-08-10 | $27.98K 10-Q · filed 2022-08-10 | $47.47K derived: sum of 3 quarters · filed 2022-08-10 | $48.63K derived: sum of 4 quarters · filed 2022-08-10 | ||||||
| 2021-03-31 | $22.06K 10-Q · filed 2022-05-11 | $41.54K derived: sum of 2 quarters · filed 2022-05-11 | $42.71K derived: sum of 3 quarters · filed 2022-05-11 | $62.12K derived: sum of 4 quarters · filed 2022-05-11 | ||||||
| 2020-12-31 | $19.48K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $20.65K derived: sum of 2 quarters · filed 2022-03-24 | $40.06K derived: sum of 3 quarters · filed 2022-03-24 | $288.13K 10-K · filed 2022-03-24 | ||||||
| 2020-09-30 | $1.16K 10-Q · filed 2021-11-10 | $20.57K derived: sum of 2 quarters · filed 2021-11-10 | $268.64K 10-Q · filed 2021-11-10 | |||||||
| 2020-06-30 | $19.41K 10-Q · filed 2021-08-11 | $267.48K 10-Q · filed 2021-08-11 | ||||||||
| 2020-03-31 | $248.07K 10-Q · filed 2021-05-12 | |||||||||
| 2019-12-31 | $800.78K 10-K · filed 2021-03-25 | |||||||||
| 2012-06-30 | $2.92K 10-Q · filed 2012-08-14 | $9.99K 10-Q · filed 2012-08-14 | $9.99K derived: sum of 3 quarters · filed 2012-08-14 | $9.99K derived: sum of 4 quarters · filed 2012-08-14 | ||||||
| 2012-03-31 | $7.07K 10-Q · filed 2012-05-15 | $7.07K derived: sum of 2 quarters · filed 2012-05-15 | $7.07K derived: sum of 3 quarters · filed 2012-05-15 | $7.38K derived: sum of 4 quarters · filed 2012-08-14 | ||||||
| 2011-12-31 | $1.00 10-Q · filed 2012-02-01 | $2.00 10-Q · filed 2012-02-01 | $309.00 derived: sum of 3 quarters · filed 2012-08-14 | $949.00 derived: sum of 4 quarters · filed 2012-08-14 | $111.00 10-Q · filed 2012-02-01 | |||||
| 2011-09-30 | $1.00 10-Q · filed 2011-10-28 | $308.00 derived: sum of 2 quarters · filed 2012-08-14 | $948.00 derived: sum of 3 quarters · filed 2012-08-14 | $949.00 derived: sum of 4 quarters · filed 2012-08-14 | $110.00 10-Q · filed 2011-10-28 | |||||
| 2011-06-30 | $307.00 10-Q · filed 2012-08-14 | $947.00 10-Q · filed 2012-08-14 | $948.00 derived: sum of 3 quarters · filed 2012-08-14 | $949.00 derived: sum of 4 quarters · filed 2012-08-14 | ||||||
| 2011-03-31 | $640.00 10-Q · filed 2012-05-15 | $641.00 derived: sum of 2 quarters · filed 2012-05-15 | $642.00 derived: sum of 3 quarters · filed 2012-05-15 | |||||||
| 2010-12-31 | $1.00 10-Q · filed 2012-02-01 | $2.00 10-Q · filed 2012-02-01 | ||||||||
| 2010-09-30 | $1.00 10-Q · filed 2011-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |